🗞️ Daily Business Brief – NOV 09,2025
- Trump proposes $1,000–$2,000 tariff dividend – Calls people opposing tariffs “fools”; claims tariff revenues will fund payments to Americans.
- CII proposes an India Development & Strategic Fund to boost long-term growth and economic resilience.
- Centre earns ₹800 crore from scrap sales in October, exceeding Chandrayaan-3 mission cost.
- Havells to pay ₹129.6 cr to HPL Group in final settlement; HPL waives rights to use ‘Havells’ brand going forward.
- Biocon receives 2 US FDA observations for API Unit (Site 6), Visakhapatnam, after Nov 3–7 inspection.
- Japan resumes seafood exports to China after two-year Fukushima wastewater ban.
- Deep-sea fishing rules updated – priority to Fishermen Cooperatives & FFPOs to undertake deep-sea fishing operations.
- Aurionpro Solutions eyes ₹5,000 cr revenue by FY30; CEO says long-term fundamentals remain strong.
- SEBI warns investors against Digital Gold / E-Gold products.
- NSE CEO says India could be the biggest winner in the global AI race.
- SML Isuzu October sales up 36% YoY; production rises over 1,200 units.
- Ashoka Buildcon bags ₹539 crore project from North Western Railway.
- US grants Hungary sanctions exemption after Trump–Orban talks.
- HAL signs deal with GE Aerospace for procurement of 97 jet engines.
- Zydus Lifesciences secures USFDA tentative approval for Olaparib tablets.
- NBCC bags ₹350 crore PMC order from Heavy Vehicles Factory.
- Moody’s downgrades Ola; flags risk of loan covenant breach.
- Adani’s Kutch smelter signs MoU for 71,000 tonnes copper supply annually from Australian project.
- Mahindra Group targets 10–20% export growth in key markets.
- Apollo Hospitals plans Q4 FY26 listing of HealthCo after restructuring.
- JSW in talks with Japan & South Korea firms for EV battery JV to reduce China reliance.
- Paytm launches AI-powered travel app ‘Paytm Check-in’.
- Lupin Bio-research center gets zero FDA observations after successful inspection.
- Sri Lotus Developers incorporates subsidiary ‘Rise Root Projects’ to expand real estate footprint.
- Hexaware completes acquisition of Cybersolve India & Global Identity/Access Solutions businesses.
- TV Ad Volumes drop as FMCG companies shift budgets to digital amid margin pressures.
- US Supreme Court seen 80% likely to strike down Trump’s tariffs under IEEPA.
- US Visa Rules may deny entry to applicants with diabetes, obesity & chronic health conditions per new directive.
- Krsnaa Diagnostics projects 20%+ growth; to add 200+ diagnostic centers and scale AI automation.
- Aarti Drugs targets sustained double-digit growth; EBITDA up 23% YoY; backward integration boosting margins.
- Finolex Industries guides steady growth; PBT doubled; strong liquidity supports capacity expansion.
- RRP Defense incorporates subsidiary ‘Vimananu Ltd’ to expand drone & defense manufacturing.
- Prince Pipes expands Bihar plant Phase-2; targets 15% annual volume growth via CPVC & bathware lines.
- Torrent Pharma projects robust growth across India & US; focusing on chronic & specialty segments.
- Sandur Manganese invests ₹2,000 cr to diversify into steel & energy; targets long-term cost efficiency.
- Pitti Engineering invests ₹500 cr in new Hyderabad facility; aims 20%+ revenue growth via high-margin components.
- Jupiter Hospitals targets 15% revenue growth; new Dombivli & South Pune facilities by 2028.
- Puravankara expands across metro markets; Q2 sales ₹1,322 cr, realizations up 8% YoY.
- Mamata Machinery targets 20% growth; expanding export-led packaging & co-extrusion lines.
- Trent continues aggressive retail expansion; aims 25–30% annual growth via Tier-2 & Tier-3 penetration.
- NALCO plans ₹7,000 cr capex under Vision 2047 for smelter, refinery upgrades & renewable integration.
- Lloyds Engineering Works reports 20% growth; expanding into defense & industrial automation.
- Piramal Finance scaling retail loans to ₹60,000+ cr; focusing on MSME, housing & digital lending network.
🔔 Stay tuned for daily insights into India Inc, markets & macro stories!
